We hypothesized that USP47 may be associated with CKD vascular calcification by regulating osteogenic transdifferentiation of the VSMC phenotype, thus suggesting a novel and potentially effective therapeutic target for patients with CKD vascular calcification. The gene discussed is USP47; the disease is chronic kidney disease.